Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Trial to Assess Safety, Tolerability Efficacy and Pharmacokinetics of CEB-01 PLGA Membrane in Participants With Pancreatic Cancer.

NCT06538857 is registered in ClinicalTrials.gov with CEBIOTEX as lead sponsor.

NCT NCT06538857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Trial to Assess Safety, Tolerability Efficacy and Pharmacokinetics of CEB-01 PLGA Membrane in Participants With Pancreatic Cancer.
Lead sponsor
CEBIOTEX
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 20, 2024
Completion date
September 30, 2028
Enrollment
39 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic carcinoma